Thursday, 23 May 2019

Extracorporeal Membrane Oxygenation System Market Growth Analysis to 2026


Extracorporeal membrane oxygenation system is a life supporting system providing cardiac and respiratory support to the patients suffering from severe respiratory failure. ECMO circuit comprises cannulas, pump, blender and oxygenator, which oxygenates the blood and remove carbon dioxide through extracorporeal gas exchange device referred as membrane oxygenator. The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. Potential indications for which ECMO is used includes severe acute respiratory distress syndrome (ARDS), acute hypercapnic respiratory failure, to bridge lung transplantation, primary graft dysfunction post-lung transplantation, and pulmonary hypertension with right ventricular failure.


The global ECMO system market was valued at US$ 248.2 million in 2017, and is expected to witness a CAGR of 5.3 % over the forecast period (2018 – 2026).

Prevalence of Cardiac and Respiratory Diseases are Boosting Growth of the Extracorporeal Membrane Oxygenation System Market

Increasing cases of cardiovascular and respiratory disorders is one of the major factors that is boosting growth of the ECMO system market. For instance, according to World Health Organization (WHO), around 31% of total global deaths was due to cardiovascular disease in 2015, which accounted to nearly 17.7 million deaths. According to European Heart Network AISBL, about 3.9 million and over 1.8 million deaths occurs every year in Europe and European Union respectively, which accounted to nearly 45% of all deaths in European Union. Another factor expected for the growing success of ECMO system market over the forecast period is the rising number of organ transplant surgeries across the globe. For instance, according to Organ and Tissue Authority of Australian Government, the number of surgeries performed for organ transplant in 2017 were around 1,469. Moreover, according to Australia and New Zealand Organ Donation Registry around 1,400 Australians are waiting for organ transplant at any given time.

Also, high prevalence of diseases will lead to increasing demand for extracorporeal membrane oxygenation system in hospitals and surgical centers. For instance, according to annual international registry by Extracorporeal Life Support Organization (ELSO), 65,171 patients received ECMO system in 2015, which increased to 98,840 patients in 2018 out of which 40,256 were neonatal, 22,952 pediatrics, and 35,632 adults.

Industrial Collaboration by the Key Players is Fueling Extracorporeal Membrane Oxygenation System Market

The global extracorporeal membrane oxygenation system market is operated by Medtronic Plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation and Alung technologies Inc. The industry players are adopting the strategy of collaboration focusing on development of new products. For instance, in 2018, Medtronic Plc. collaborated with the Sayler Biomedical LLC, for the development of their product Century heart Lung machine. The collaboration has made the Medtronic’s product available for customers globally. Century heart lung machine has features, such as compact and sturdy design, easy to use components and affordable price. This is expected to strengthen customer base and widen the product portfolio of Medtronic.

Detailed Segmentation:

Global Extracorporeal Membrane Oxygenation System Market, By Modality:
  • Arteriovenous
  • Venoarteial
  • Venovenous

Global Extracorporeal Membrane Oxygenation System Market, By Application:
  • Extracorporeal cardiopulmonary resuscitation
  • Cardiac
  • Respiratory


About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

CMI Research Reports at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)